← Shandong Dongyue Organosilicon Mat overview

Shandong Dongyue Organosilicon Mat vs Axalta Coating Systems: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Shandong Dongyue Organosilicon Mat (300821.CS)

Q3 2026
▲3

Dongyue Silicone profit jumps 916% on higher prices, cheaper raw materials

  • First-half profit forecast up 905%-952% Dongyue Silicone told investors it expects first-half 2026 net profit of 424-444 million yuan, up roughly 905%-952% from a year earlier. The company credits higher silicone selling prices and cheaper raw materials, which fattened its gross margin. That is the core reason the stock is moving.

    This is the first hard signal of the profit surge that drives the stock.

  • Actual interim report confirms 916% profit growth The final half-year report showed net profit of 429 million yuan, up 916%, on revenue of 2.665 billion yuan, up 14.5%. Second-quarter profit rose about 20% from the first quarter, so the improvement kept building through the period rather than fading. No dividend was declared.

    It confirms the earlier forecast was real and shows momentum continued into Q2.

  • Silicone price upcycle lifts the whole chemical sector Several chemical and materials companies reported huge profit jumps in the same period, pointing to a broad rise in product prices and easing raw-material costs. For Dongyue, this means the profit boost is not a one-off company quirk but part of an industry pricing cycle that can persist.

    It shows the profit driver is industry-wide, not a one-time event.

  • No dividend and one-off gains temper the good news The company will pay no cash dividend, and about 41 million yuan of the profit came from one-off items like asset sales, not core operations. So while the headline growth is real, part of it is not repeatable, and shareholders get no cash back this half.

    It is the main counterweight investors should weigh against the strong headline.

July 2026
▲3

Dongyue Silicone profit jumps 916% on higher prices, cheaper raw materials

  • First-half profit forecast up 905%-952% Dongyue Silicone told investors it expects first-half 2026 net profit of 424-444 million yuan, up roughly 905%-952% from a year earlier. The company credits higher silicone selling prices and cheaper raw materials, which fattened its gross margin. That is the core reason the stock is moving.

    This is the first hard signal of the profit surge that drives the stock.

  • Actual interim report confirms 916% profit growth The final half-year report showed net profit of 429 million yuan, up 916%, on revenue of 2.665 billion yuan, up 14.5%. Second-quarter profit rose about 20% from the first quarter, so the improvement kept building through the period rather than fading. No dividend was declared.

    It confirms the earlier forecast was real and shows momentum continued into Q2.

  • Silicone price upcycle lifts the whole chemical sector Several chemical and materials companies reported huge profit jumps in the same period, pointing to a broad rise in product prices and easing raw-material costs. For Dongyue, this means the profit boost is not a one-off company quirk but part of an industry pricing cycle that can persist.

    It shows the profit driver is industry-wide, not a one-time event.

  • No dividend and one-off gains temper the good news The company will pay no cash dividend, and about 41 million yuan of the profit came from one-off items like asset sales, not core operations. So while the headline growth is real, part of it is not repeatable, and shareholders get no cash back this half.

    It is the main counterweight investors should weigh against the strong headline.

Latest
▲3

Dongyue Silicone profit jumps 916% on higher prices, cheaper raw materials

  • First-half profit forecast up 905%-952% Dongyue Silicone told investors it expects first-half 2026 net profit of 424-444 million yuan, up roughly 905%-952% from a year earlier. The company credits higher silicone selling prices and cheaper raw materials, which fattened its gross margin. That is the core reason the stock is moving.

    This is the first hard signal of the profit surge that drives the stock.

  • Actual interim report confirms 916% profit growth The final half-year report showed net profit of 429 million yuan, up 916%, on revenue of 2.665 billion yuan, up 14.5%. Second-quarter profit rose about 20% from the first quarter, so the improvement kept building through the period rather than fading. No dividend was declared.

    It confirms the earlier forecast was real and shows momentum continued into Q2.

  • Silicone price upcycle lifts the whole chemical sector Several chemical and materials companies reported huge profit jumps in the same period, pointing to a broad rise in product prices and easing raw-material costs. For Dongyue, this means the profit boost is not a one-off company quirk but part of an industry pricing cycle that can persist.

    It shows the profit driver is industry-wide, not a one-time event.

  • No dividend and one-off gains temper the good news The company will pay no cash dividend, and about 41 million yuan of the profit came from one-off items like asset sales, not core operations. So while the headline growth is real, part of it is not repeatable, and shareholders get no cash back this half.

    It is the main counterweight investors should weigh against the strong headline.

Axalta Coating Systems Ltd (AXTA)

Q3 2026
▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

  • EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.

    This is the biggest new force: the merger's key regulatory hurdle is being cleared.

  • Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.

    The quarter's results are the core fundamental driver behind the shares.

  • Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.

    These steps reduce deal risk and show the partner is financially healthy.

  • Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.

    This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.

August 2026
▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

  • EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.

    This is the biggest new force: the merger's key regulatory hurdle is being cleared.

  • Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.

    The quarter's results are the core fundamental driver behind the shares.

  • Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.

    These steps reduce deal risk and show the partner is financially healthy.

  • Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.

    This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.

Latest
▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

  • EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.

    This is the biggest new force: the merger's key regulatory hurdle is being cleared.

  • Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.

    The quarter's results are the core fundamental driver behind the shares.

  • Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.

    These steps reduce deal risk and show the partner is financially healthy.

  • Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.

    This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.